The University of Chicago Header Logo

Connection

Stephen Hanauer to Fibroblast Growth Factor 10

This is a "connection" page, showing publications Stephen Hanauer has written about Fibroblast Growth Factor 10.
Connection Strength

0.056
  1. Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Aliment Pharmacol Ther. 2003 Jun 01; 17(11):1355-64.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.